retatrutide clinical trial results 2025 side effects trials Today's TRIUMPH-4 are a clear signal: the next New Obesity Drug Helped People

A recent study on semaglutide specifically demonstrated that the medication reduces appetite while simultaneously increasing dopamine reward signaling in the brain, suggesting that it does not simply blunt pleasure but rather redirects it

Who they do not suit Injections are not suitable if you are pregnant, planning pregnancy, or breastfeeding

Endocrinology (1999) 140(11):535663

GLP-1 medications change appetite, hunger cues, and interest in food

If nausea and GI symptoms feel unbearable at a particular dose level, the correct move is to hold at that dose longer, not to push through to the next escalation

An apparent paradox is that whereas GLP-1 increases glucose-stimulated insulin secretion in the isolated pancreas fulfilling the definition of an incretin but it lowers insulin secretion in physiologically relevant conditions [6, 10, 18]